Who to call at Autolus Therapeutics plc, and when
Fundz watches for the moments Autolus Therapeutics plc starts buying, and tells you who to reach.
- An alert the day Autolus Therapeutics plc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Autolus Therapeutics plc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Autolus Therapeutics plc. With Fundz connected, it knows.
Autolus Therapeutics plc
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
www.autolus.comAI Executive Summary
AI-powered analysis of 8-K filing content
Autolus Therapeutics plc reported its results for the quarter ended September 30, 2025, and disclosed that CFO Rob Dolski will step down as Principal Accounting Officer while remaining CFO and Principal Financial Officer. Patrick McIlvenny was appointed Principal Accounting Officer, effective November 7, 2025, with no additional compensation.
Key Takeaways
Rob Dolski notified the company on November 7, 2025, that he would resign as Principal Accounting Officer, but he remains Chief Financial Officer and Principal Financial Officer.
The Board appointed Patrick McIlvenny as Principal Accounting Officer on November 10, 2025, effective November 7, 2025, so the change is backdated to the date of Dolski's notice.
2 more takeaways
Related Filings (12)
12 more filings from Autolus Therapeutics plc in the last 90 days
Filing Overview
What This Means
Autolus Therapeutics plc filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.